Siemens Healthineers (ETR:SHL) has been assigned a €55.00 ($64.71) price objective by equities researchers at Credit Suisse Group in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. The firm currently has a “buy” rating on the stock. Credit Suisse Group’s target price suggests a potential upside of 13.59% from the company’s current price.
A number of other equities analysts have also weighed in on the stock. UBS Group set a €46.00 ($54.12) price target on shares of Siemens Healthineers and gave the company a “neutral” rating in a report on Tuesday, February 23rd. Independent Research set a €48.00 ($56.47) target price on Siemens Healthineers and gave the company a “neutral” rating in a report on Friday, March 26th. Berenberg Bank set a €56.00 ($65.88) price target on Siemens Healthineers and gave the stock a “buy” rating in a research note on Thursday, April 29th. Deutsche Bank Aktiengesellschaft set a €46.00 ($54.12) price objective on Siemens Healthineers and gave the company a “neutral” rating in a research note on Monday, February 8th. Finally, Royal Bank of Canada set a €42.00 ($49.41) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research report on Tuesday, January 26th. Six analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of €49.28 ($57.98).
SHL opened at €48.42 ($56.96) on Tuesday. Siemens Healthineers has a 1 year low of €35.58 ($41.85) and a 1 year high of €49.99 ($58.81). The company’s 50 day simple moving average is €47.01 and its 200 day simple moving average is €43.54. The stock has a market capitalization of $54.57 billion and a PE ratio of 32.24. The company has a debt-to-equity ratio of 45.68, a quick ratio of 1.02 and a current ratio of 1.36.
Siemens Healthineers Company Profile
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.
Further Reading: Special Dividends
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.